Healx
Cambridge, GB · Founded 2014 · 10 known investors
Find your way into Healx
438 people in our graph share verified history with the Healx team — schools, employers, funds. One of them is your warm intro.
Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence. The company runs multiple drug discovery programmes in parallel, bringing candidate treatments from prediction through clinical trials.
Founders & leadership
Healx was founded in 2014 by Tim Guilliams and Dr David Brown.

Investors · 10
How we know: Amadeus Capital Partners's portfolio page · Not right? Tell us
How we know: Cambridge Angels group's portfolio page · Not right? Tell us
How we know: Daniel Gutenberg's portfolio page · Not right? Tell us
How we know: Intel Capital's portfolio page · Not right? Tell us
How we know: SCI Ventures's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
Funding
SEC filings, press & company announcements$47M disclosed across 1 of 3 rounds · 2019–2024
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Healx went on to found or lead other companies.
Companies House · registry record
View on Companies House ↗- Registered name
- HEALX LIMITED
- Company number
- 09018507
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 30 Apr 2014
- Registered office
- 3rd Floor Charter House, 66-68 Hills Road, Cambridge, CB2 1LA
- Nature of business (SIC)
- 74909 — Other professional, scientific and technical activities n.e.c.
- Previous names
- HEALX3 LIMITED (2014–2015)
- Accounts
- last made up to 31 Dec 2024 · next due 31 Dec 2026
- Confirmation statement
- last made up to 30 Apr 2026 · next due 14 May 2027
Current officers · 6
- Ohs Secretaries Limited — corporate secretary, appointed 14 Apr 2026
- David Brown — director, appointed 15 Oct 2015
- Suranga Chandratillake — director, appointed 18 Jun 2018
- Laura Elizabeth Connell — director, appointed 4 Apr 2025
- Tim Thomas Guilliams — director, appointed 30 Apr 2014
- Jonathan Simon Milner — director, appointed 22 Jul 2016
Source: Companies House public register · retrieved 27 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Healx do?
- Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence. The company runs multiple drug discovery programmes in parallel, bringing candidate treatments from prediction through clinical trials.
- Who founded Healx?
- Healx was founded by Tim Guilliams, Dr David Brown in 2014.
- Who are Healx's investors?
- Healx's investors include Amadeus Capital Partners, Aurum Venture Partners, Balderton Capital, Cambridge Angels group, Daniel Gutenberg, Intel Capital, SCI Ventures, VU Venture Partners and 2 more.
- How much funding has Healx raised?
- Healx has disclosed $47M raised across 1 of its 3 known rounds.
- Where is Healx headquartered?
- Healx is headquartered in Cambridge, GB.











